Circulating levels of sex steroids and prolactin in premenopausal women and risk of breast cancer

Advances in Experimental Medicine and Biology

Volumn 617, Issue , 2008, Pages 161-169

  Hankinson, Susan E ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

PROLACTIN; SEX HORMONE;

BREAST CANCER; CANCER RISK; CONFERENCE PAPER; CONTROLLED STUDY; FEMALE; HORMONE BLOOD LEVEL; HUMAN; MAJOR CLINICAL STUDY; PREMENOPAUSE; PRIORITY JOURNAL; QUESTIONNAIRE; ADULT; ARTICLE; BLOOD; BREAST TUMOR; CASE CONTROL STUDY; COHORT ANALYSIS; COMPARATIVE STUDY; MIDDLE AGED; PROSPECTIVE STUDY; RISK FACTOR;

ADULT; BREAST NEOPLASMS; CASE-CONTROL STUDIES; COHORT STUDIES; FEMALE; GONADAL STEROID HORMONES; HUMANS; MIDDLE AGED; PREMENOPAUSE; PROLACTIN; PROSPECTIVE STUDIES; RISK FACTORS;

EID: 46749109263     PISSN: 00652598     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-0-387-69080-3_15     Document Type: Conference Paper

References (36)

1. Hankinson SE, Colditz GA, Willett WC (2004) Towards an integrated model for breast cancer etiology: the lifelong interplay of genes, lifestyle, and hormones. Breast Cancer Res 6:213-8.
2. Cummings SR, Eckert S, Krueger KA, et al. (1999) The effect of raloxifene on risk of breast cancer in postmenopausal women: results from the MORE randomized trial. Multiple Outcomes of Raloxifene Evaluation. JAMA 281:2189-97.
3. Cuzick J, Powles T, Veronesi U, et al. (2003) Overview of the main outcomes in breast-cancer prevention trials. Lancet 361:296-300.
4. Key T, Appleby P, Barnes I, et al. (2002) Endogenous sex hormones and breast cancer in postmenopausal women: reanalysis of nine prospective studies. J Natl Cancer Inst 94:606-16.
5. Missmer SA, Eliassen AH, Barbieri RL, et al. (2004) Endogenous estrogen, androgen, and progesterone concentrations and breast cancer risk among postmenopausal women. J Natl Cancer Inst 96:1856-65.
6. Kaaks R, Rinaldi S, Key TJ, et al. (2005) Postmenopausal serum androgens, oestrogens and breast cancer risk: the European prospective investigation into cancer and nutrition. Endocr Relat Cancer 12:1071-82.
7. Tworoger SS, Sluss P, Hankinson SE (2006) Association between plasma prolactin concentrations and risk of breast cancer among predominately premenopausal women. Cancer Res 66:2476-82.
8. Eliassen AH, Missmer SA, Tworoger SS, et al. (2006) Endogenous steroid hormone concentrations and risk of breast cancer among premenopausal women. JNCI 98:1406-15.
9. Tworoger SS, Missmer SA, Eliassen AH, et al. (2006) The association of plasma DHEA and DHEA sulfate with breast cancer risk in predominantly premenopausal women. Cancer Epidemiol Biomarkers Prev 15:967-71.
10. Henderson BE, Feigelson HS (2000) Hormonal carcinogenesis. Carcinogenesis 21:427-33.
11. Kabuto M, Akiba S, Stevens RG, et al. (2000) A prospective study of estradiol and breast cancer in Japanese women. Cancer Epidemiol Biomarkers Prev 9:575-9.
12. Rosenberg CR, Pasternack BS, Shore RE, et al. (1994) Premenopausal estradiol levels and the risk of breast cancer: a new method of controlling for day of the menstrual cycle. Am J Epidemiol 140:518-25.
13. Thomas HV, Key TJ, Allen DS, et al. (1997) A prospective study of endogenous serum hormone concentrations and breast cancer risk in premenopausal women on the island of Guernsey. Br J Cancer 75:1075-9.
14. Helzlsouer KJ, Alberg AJ, Bush TL, et al. (1994) A prospective study of endogenous hormones and breast cancer. Cancer Detect Prev 18:79-85.
15. Wysowski DK, Comstock GW, Helsing KJ, et al. (1987) Sex hormone levels in serum in relation to the development of breast cancer. Am J Epidemiol 125:791-9.
16. Kaaks R, Berrino F, Key T, et al. (2005) Serum sex steroids in premenopausal women and breast cancer risk within the European Prospective Investigation into Cancer and Nutrition (EPIC). J Natl Cancer Inst 97:755-65.
17. Liao DJ, Dickson RB (2002) Roles of androgens in the development, growth, and carcinogenesis of the mammary gland. J Steroid Biochem Mol Biol 80:175-89.
18. Ebeling P, Koivisto VA (1994) Physiological importance of dehydroepiandrosterone. Lancet 343:1479-81.
19. Seymour-Munn K, Adams J (1983) Estrogenic effects of 5-androstene-3 beta, 17 beta-diol at physiological concentrations and its possible implication in the etiology of breast cancer. Endocrinology 112:486-91.
20. Micheli A, Muti P, Secreto G, et al. (2004) Endogenous sex hormones and subsequent breast cancer in premenopausal women. Int J Cancer 112:312-8.
21. Page JH, Colditz GA, Rifai N, et al. (2004) Plasma adrenal androgens and risk of breast cancer in premenopausal women. Cancer Epidemiol Biomarkers Prev 13:1032-6.
22. Wang DY, Allen DS, De Stavola BL, et al. (2000) Urinary androgens and breast cancer risk: results from a long-term prospective study based in Guernsey. Br J Cancer 82:1577-84.
23. Helzlsouer KJ, Gordon GB, Alberg AJ, et al. (1992) Relationship of prediagnostic serum levels of dehydroepiandrosterone and dehydroepiandrosterone sulfate to the risk of developing premenopausal breast cancer. Cancer Res 52:1-4.
24. Freeman ME, Kanyicska B, Lerant A, et al. (2000) Prolactin: structure, function, and regulation of secretion. Physiol Rev 80:1523-631.
25. Clevenger CV, Furth PA, Hankinson SE, et al. (2003) The role of prolactin in mammary carcinoma. Endocr Rev 24:1-27.
26. Partridge RK, Hahnel R (1979) Prolactin receptors in human breast carcinoma. Cancer 43:643-6.
27. Wang DY, De Stavola BL, Bulbrook RD, et al. (1992) Relationship of blood prolactin levels and the risk of subsequent breast cancer. Int J Epidemiol 21:214-21.
28. Hankinson SE, Willett WC, Manson JE, et al. (1998) Plasma sex steroid hormone levels and risk of breast cancer in postmenopausal women. J Natl Cancer Inst 90:1292-9.
29. Sodergard R, Backstrom T, Shanbhag V, et al. (1982) Calculation of free and bound fractions of testosterone and estradiol-17 beta to human plasma proteins at body temperature. J Steroid Biochem 16:801-10.
30. Santoro N, Lasley B, McConnell D, et al. (2004) Body size and ethnicity are associated with menstrual cycle alterations in women in the early menopausal transition: The Study of Women's Health across the Nation (SWAN) Daily Hormone Study. J Clin Endocrinol Metab 89:2622-31.
31. Landgren BM, Collins A, Csemiczky G, et al. (2004) Menopause transition: Annual changes in serum hormonal patterns over the menstrual cycle in women during a nine-year period prior to menopause. J Clin Endocrinol Metab 89:2763-9.
32. Desreux J, Kebers F, Noel A, et al. (2003) Effects of a progestogen on normal human breast epithelial cell apoptosis in vitro and in vivo. Breast 12:142-9.
33. Gompel A, Somai S, Chaouat M, et al. (2000) Hormonal regulation of apoptosis in breast cells and tissues. Steroids 65:593-8.
34. Stute P, Wood CE, Kaplan JR, et al. (2004) Cyclic changes in the mammary gland of cynomolgus macaques. Fertil Steril 82 (Suppl 3):1160-70.
35. Adams JB (1998) Adrenal androgens and human breast cancer: a new appraisal. Breast Cancer Res Treat 51:183-8.
36. Tworoger SS, Eliassen AH, Rosner B, et al. (2004) Plasma prolactin concentrations and risk of postmenopausal breast cancer. Cancer Res 64:6814-9.